We recently received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it.

Mailing List

Please fill out the following information to join our mailing list.

 
 
 
 

What are you most interested in?

Select all that apply:

 

By clicking "Subscribe,” you agree to receive updates by email about Neuralink as well as Neuralink’s products and activities such as Neuralink’s Patient Registry. To learn more, including how to unsubscribe, visit our Privacy Policy.